about
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study.Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantationNutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects.Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer.Cancer and Thrombosis-New Insights
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Drug-related thrombosis in hematologic malignancies.
@ast
Drug-related thrombosis in hematologic malignancies.
@en
type
label
Drug-related thrombosis in hematologic malignancies.
@ast
Drug-related thrombosis in hematologic malignancies.
@en
prefLabel
Drug-related thrombosis in hematologic malignancies.
@ast
Drug-related thrombosis in hematologic malignancies.
@en
P1476
Drug-related thrombosis in hematologic malignancies.
@en
P2093
Ron Hoffman
Yona Nadir
P577
2004-06-01T00:00:00Z